CLINICAL_TRIALS
trial_result
· 2022-08-05
Clinical Trial Update: Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating inhaled interferon α2b for treating COVID-19 has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Coronavirus Disease 2019 | Phase 1, Phase 2 | Status: COMPLETED